Market revenue in 2024 | USD 219.6 million |
Market revenue in 2030 | USD 245.0 million |
Growth rate | 1.8% (CAGR from 2025 to 2030) |
Largest segment | Conventional |
Fastest growing segment | Molecular |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Molecular, Conventional |
Key market players worldwide | BioMerieux SA, Abbott, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG ADR, Becton Dickinson & Co, Qiagen NV, Thermo Fisher Scientific Inc, Meridian Bioscience, Hologic, Inc. |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hospital acquired infections diagnostics market will help companies and investors design strategic landscapes.
Conventional was the largest segment with a revenue share of 53.87% in 2024. Horizon Databook has segmented the Brazil hospital acquired infections diagnostics market based on molecular, conventional covering the revenue growth of each sub-segment from 2018 to 2030.
The HAI diagnostics market in Brazil is dominated by a mix of global leaders as well as local players such as Fleury Group and Diagnósticos da América S.A. (DASA). Global companies leverage advanced molecular diagnostics and automation to provide high-throughput solutions, while local firms focus on tailored offerings for specific pathogens prevalent in Brazilian hospitals.
Recent developments include Thermo Fisher's expansion of its diagnostic portfolio to address multidrug-resistant organisms, while DASA has invested in laboratory infrastructure and partnerships to enhance diagnostic accessibility.
Strategies in Brazil revolve around partnerships with public health institutions, localized manufacturing to reduce costs, and research collaborations to address region-specific HAIs, such as carbapenemresistant Enterobacteriaceae.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil hospital acquired infections diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Brazil hospital acquired infections diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account